#aurobindopharma
Amazon acetaminophen recall: 112,932 bottles over discoloration
The Amazon acetaminophen recall covers 112,932 bottles of extra-strength 500mg caplets distributed across the United States. Aurobindo Pharma initiated the voluntary action following complaints about discolored tablets. Consumers should check affected lot numbers and expiration dates. Tags — 9 lowercase amazonrecall, acetaminophenrecall, fdarecall, aurobindopharma, drugrecall, medicationsafety, painrelief, consumeralerts, usnews More than 112,000 bottles of Ama
Amazon acetaminophen recall: 112,932 bottles over discoloration
The Amazon acetaminophen recall covers 112,932 bottles of extra-strength 500mg caplets distributed across the United States. Aurobindo Pharma initiated the voluntary action following complaints about discolored tablets. Consumers should check affected lot numbers and expiration dates. Tags — 9 lowercase amazonrecall, acetaminophenrecall, fdarecall, aurobindopharma, drugrecall, medicationsafety, painrelief, consumeralerts, usnews More than 112,000 bottles of Ama
Trump announces 100 percent tariffs on branded drugs, India pharma may face big hit
Washington: US President Donald Trump has announced sweeping new tariffs on imported pharmaceutical products, a move that could trigger widespread consequences for the global drug trade and India’s pharmaceutical sector in particular. Effective October 1, 2025, Washington will impose tariffs of up to 100 percent on branded and patented pharmaceutical drugs unless the manufacturing companies are building their production facilities within the United States. The president emphasized that
Trump announces 100 percent tariffs on branded drugs, India pharma may face big hit
Washington: US President Donald Trump has announced sweeping new tariffs on imported pharmaceutical products, a move that could trigger widespread consequences for the global drug trade and India’s pharmaceutical sector in particular. Effective October 1, 2025, Washington will impose tariffs of up to 100 percent on branded and patented pharmaceutical drugs unless the manufacturing companies are building their production facilities within the United States. The president emphasized that









